Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-05-27

FDA Approved: VIBERZI — Original Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved VIBERZI (eluxadoline) from Allergan as the original approval for treating irritable bowel syndrome. This marks the introduction of this medicat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viberzi (eluxadoline)

Snippet

ORIG AP for VIBERZI (ELUXADOLINE)